CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Autologous stem cell transplantationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04760184
NCT04760184N/ACompleted
CompareCT.gov

Impact of COVID-19 on Patients Treated With Autologous Hematopoietic Stem Cell Transplantation in Sweden - a Retrospective Cohort Study

Uppsala University·observational·Posted Feb 18, 2021·Updated Feb 8, 2022

In Brief

An observational study evaluating Autologous stem cell transplantation for Covid19 and 4 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This retrospective observational cohort study aims to describe the impact of COVID-19 in patients treated with autologous stem cell transplantation (ASCT) for malignant disease in terms of risk factors, morbidity, need for supportive care and mortality. All patients treated with ASCT in Sweden from 1st January 2020 until 31st December 2020 are eligible for this study. Patients who also has tested positive for SARS-CoV-2 from start of conditioning or later will be identified through the national registry of the Public Health Agency of Sweden and a systematic analysis of their medical records will be performed.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19, Myeloma Multiple, Malignant Lymphoma, Hematologic Neoplasms, Stem Cell Transplant Complications
CountriesSweden
CollaboratorsKarolinska University Hospital, Sahlgrenska University Hospital, Lund University Hospital, University Hospital, Linkoeping, University Hospital, Umeå, Region Örebro County, Uppsala University Hospital

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 18, 2021
Enrollment StartApr 1, 2021
Primary CompletionAug 30, 2021
Study CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5.4 years ago

Interventions

Autologous stem cell transplantationother

The study will describe the implications of COVID-19 infection following autologous stem cell transplantation